Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support
Fierce Pharma
Tuesday, October 8, 2024 - 9:52pm
tags:
Pfizer, hurricane, Florida
Startup led by John Maraganore raises $135M to build ‘future of RNAi’
BioPharma Dive
Tuesday, October 8, 2024 - 9:50pm
tags:
City Therapeutics, funding, RNAi, John Maraganore
Execs, sale reps charged in $1.3B prescription drug operation
Beckers Hospital Review
Tuesday, October 8, 2024 - 9:49pm
tags:
DOJ, legal, opioids
GSK says RSV vaccine protects against disease over three seasons
BioPharma Dive
Tuesday, October 8, 2024 - 9:47pm
tags:
GSK, RSV, vaccines, clinical trials
Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
Fierce Pharma
Tuesday, October 8, 2024 - 11:19am
tags:
Merck, clinical trials, Keytruda, head and neck cancer
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
Reuters
Tuesday, October 8, 2024 - 11:17am
tags:
GSK, Pfizer, RSV, vaccines
PTC puts Friedreich ataxia drug's past failures in the rearview with long-term data drop
Fierce Biotech
Tuesday, October 8, 2024 - 11:12am
tags:
PTC Therapeutics, Friedreich’s ataxia, vatiquinone
Neuvivo files NDA seeking FDA approval for ALS treatment
Pharmaceutical Business Review
Tuesday, October 8, 2024 - 10:15am
tags:
Neuvivo, FDA, ALS, NP001
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Reuters
Tuesday, October 8, 2024 - 10:13am
tags:
Pfizer, BioNTech, CureVac, patents, COVID-19, vaccines, legal
Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
Clinical Trials Arena
Tuesday, October 8, 2024 - 9:56am
tags:
Boehringer Ingelheim, MASH, clinical trials, survodutide
Sage scraps Alzheimer's program as dalzanemdor goes 0 for 2, leaving hopes resting on Huntington's
Fierce Biotech
Tuesday, October 8, 2024 - 9:53am
tags:
SAGE Therapeutics, Alzheimer's disease, dalzanemdor, clinical trials
Oncolytics targets accelerated approval for oncolytic virus therapy
Clinical Trials Arena
Tuesday, October 8, 2024 - 9:50am
tags:
Oncolytics, oncolytic viruses, pelareop, clinical trials, breast cancer
How extreme weather could lead to drug shortages
Axios
Tuesday, October 8, 2024 - 9:47am
tags:
climate change, drug shortages, RAND
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tuesday, October 8, 2024 - 9:45am
tags:
R&D, obesity, weight loss, Novo Nordisk, Eli Lilly, Roche, Boehringer Ingelheim
Astellas places $2bn+ bet on AviadoBio dementia gene therapy
Pharmaphorum
Tuesday, October 8, 2024 - 9:44am
tags:
Astellas, gene therapy, AviadoBio, frontotemporal dementia
J&J discontinues late-stage study for bladder cancer drug
Reuters
Monday, October 7, 2024 - 10:01pm
tags:
JNJ, bladder cancer, clinical trials, TAR-200
CAMP4 is latest biotech to eye IPO, while Upstream spells out $182M plans
Fierce Biotech
Monday, October 7, 2024 - 9:58pm
tags:
CAMP4 Therapeutics, IPOs, Upstream Bio, RNA
Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case
Fierce Pharma
Monday, October 7, 2024 - 9:56pm
tags:
Mylan Labs, Natco, Novo Nordisk, Ozempic, generics, patents, legal
Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test
Medtech Dive
Monday, October 7, 2024 - 9:54pm
tags:
undefined
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Monday, October 7, 2024 - 9:52pm
tags:
AbbVie, Skyrizi, Crohn's Disease, psoriatic arthritis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.